Skip to content

Follow meridian rapid acupuncture combined with 'Huoxuelishang' plaster in the treatment of blood stasis type lumbar disc herniation, a randomized single blind placebo-controlled trial

Follow meridian rapid acupuncture combined with 'Huoxuelishang' plaster in the treatment of blood stasis type lumbar disc herniation, a randomized single blind placebo-controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087283
Enrollment
Unknown
Registered
2024-07-24
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Disc Herniation (LDH)

Interventions

rapid acupuncture group:rapid acupuncture + 'Huoxuelishang' plaster
sham acupuncture group:sham acupuncture + 'Huoxuelishang' plaster

Sponsors

Yangpu Hospital, School of Medicine, Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients who met the diagnostic criteria were classified as mild or moderate LDH (2) Aged 18-75 years; (3) The duration of the disease is more than 3 months; (4) Voluntarily accept the external treatment of quick acupuncture combined with Huoxueliang ointment to complete the requirements. (5) Patients did not receive oral, intravenous, intramuscular, or soft tissue injections of glucocorticoids during the first 4 weeks of treatment; (6) After fully understanding this experiment, agree to join, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) In cases where the inclusion criteria are not met; 2) Have previously participated in or are currently participating in other clinical trials within the past 3 months; 3) Patients who have failed to respond to regular non-surgical therapy for a duration of six months, patients with worsened symptoms, or patients with severe symptoms; 4) Rapid and significant decline in muscle strength, with muscle strength below level III; 5) Patients with a history of severe lumbar trauma and previous lumbar surgery; 6) Pregnant women, breastfeeding women, and individuals with mental health conditions; 7) Individuals with allergic tendencies or allergies to multiple drugs; 8) Individuals with mental or legal incapacities; 9) Individuals with a history of opioid analgesic use, sedatives and hypnotics abuse, as well as alcohol abuse; 10) Patients diagnosed with serious primary diseases affecting the liver, kidney, hematopoietic system, endocrine system cardiovascular and cerebrovascular system,nervous system, and other major systems. This includes tuberculosis infection,vertebral malformations, malignant tumors, and mental disorders. 11)Patients who fear acupuncture.

Design outcomes

Primary

MeasureTime frame
Pain threshold;pain tolerance threshold;

Secondary

MeasureTime frame
VAS;JOA;

Countries

China

Contacts

Public ContactJiang Bin

TCM Department, Yangpu Hospital, School of Medicine, Tongji University

13262280669@163.com+86 132 6228 0669

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026